DE69017946D1 - Zellwachstum hemmende makrozyklische Lactone namens Combretastatin D-2. - Google Patents

Zellwachstum hemmende makrozyklische Lactone namens Combretastatin D-2.

Info

Publication number
DE69017946D1
DE69017946D1 DE69017946T DE69017946T DE69017946D1 DE 69017946 D1 DE69017946 D1 DE 69017946D1 DE 69017946 T DE69017946 T DE 69017946T DE 69017946 T DE69017946 T DE 69017946T DE 69017946 D1 DE69017946 D1 DE 69017946D1
Authority
DE
Germany
Prior art keywords
combretastatin
cell growth
called
macrocyclic lactones
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69017946T
Other languages
English (en)
Other versions
DE69017946T2 (de
Inventor
George R Pettit
Sheo Bux Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Arizona
Arizona State University ASU
Original Assignee
University of Arizona
Arizona State University ASU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Arizona, Arizona State University ASU filed Critical University of Arizona
Application granted granted Critical
Publication of DE69017946D1 publication Critical patent/DE69017946D1/de
Publication of DE69017946T2 publication Critical patent/DE69017946T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D321/00Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Detergent Compositions (AREA)
  • Lubricants (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69017946T 1989-04-26 1990-04-20 Zellwachstum hemmende makrozyklische Lactone namens Combretastatin D-2. Expired - Lifetime DE69017946T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/344,005 US4940726A (en) 1989-04-26 1989-04-26 Cell growth inhibitory macrocyclic lactones denominated Combretastatin D-1 and Combretastatin D-2

Publications (2)

Publication Number Publication Date
DE69017946D1 true DE69017946D1 (de) 1995-04-27
DE69017946T2 DE69017946T2 (de) 1995-09-14

Family

ID=23348618

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69017946T Expired - Lifetime DE69017946T2 (de) 1989-04-26 1990-04-20 Zellwachstum hemmende makrozyklische Lactone namens Combretastatin D-2.

Country Status (8)

Country Link
US (1) US4940726A (de)
EP (1) EP0397336B1 (de)
JP (1) JP2929025B2 (de)
AT (1) ATE120193T1 (de)
CA (1) CA2010886A1 (de)
DE (1) DE69017946T2 (de)
DK (1) DK0397336T3 (de)
ES (1) ES2070276T3 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3919255A1 (de) * 1989-06-13 1990-12-20 Bayer Ag Dibenzo/1,5/dioxocin-5-one-derivate, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung
US5430062A (en) * 1992-05-21 1995-07-04 Research Corporation Technologies, Inc. Stilbene derivatives as anticancer agents
US5393897A (en) * 1993-07-02 1995-02-28 Arizona Board Of Regents Acting On Behalf Of Arizona State University Isolation and structure of spongistatins 5,7,8 and 9
JP2002537262A (ja) 1999-02-18 2002-11-05 オキシジェン,インコーポレイティド 血管破壊のターゲッティングに使用するための組成物および方法
EP1185559A2 (de) 1999-04-28 2002-03-13 Board Of Regents, The University Of Texas System Zusammensetzungen und verfahren zur krebsbehandlung durch die selektive hemmung von vegf
US6703020B1 (en) * 1999-04-28 2004-03-09 Board Of Regents, The University Of Texas System Antibody conjugate methods for selectively inhibiting VEGF
US7037906B1 (en) * 2000-12-22 2006-05-02 Oxigene, Inc. Methods for modulating tumor growth and metastasis
US20050209310A1 (en) * 2000-12-22 2005-09-22 Chaplin David J Methods for modulating tumor growth and metastasis
DK1537146T3 (da) 2002-07-15 2011-04-04 Univ Texas Antistoffer, der binder til anioniske phospholipider og aminophospholipider, og deres anvendelse til behandling af virusinfektioner
US20040052868A1 (en) * 2002-09-12 2004-03-18 William Asiedu Composition treating for AIDS and associated conditions
US20090011060A1 (en) * 2007-07-06 2009-01-08 Peter Koepke Campsiandra angustifolia extract and methods of extracting and using such extract
US20090017140A1 (en) * 2007-07-09 2009-01-15 Peter Koepke Maytenus abenfolia extract and methods of extracting and using such extract
US20090035395A1 (en) * 2007-08-01 2009-02-05 Peter Koepke Spondias mombin l. extract and methods of extracting and using such extract
US7879369B2 (en) * 2007-09-18 2011-02-01 Selvamedica, Llc Combretum laurifolium Mart. extract and methods of extracting and using such extract
MX2010005104A (es) 2007-11-09 2010-08-04 Peregrine Pharmaceuticals Inc Composiciones de anticuerpo anti-factor de crecimiento endotelial vascular y metodos.
AU2008326251B2 (en) 2007-11-21 2014-03-06 Mateon Therapeutics, Inc. Method for treating hematopoietic neoplasms
US9353150B2 (en) 2012-12-04 2016-05-31 Massachusetts Institute Of Technology Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
AU2014228822A1 (en) 2013-03-15 2015-10-01 Memorial Sloan-Kettering Cancer Center HSP90-targeted cardiac imaging and therapy
WO2016130969A1 (en) 2015-02-13 2016-08-18 George Robert Pettit Silstatin compounds
US11419934B2 (en) 2015-08-18 2022-08-23 Oncotelic Therapeutics, Inc. Use of VDAS to enhance immunomodulating therapies against tumors
US10918627B2 (en) 2016-05-11 2021-02-16 Massachusetts Institute Of Technology Convergent and enantioselective total synthesis of Communesin analogs
US11932650B2 (en) 2017-05-11 2024-03-19 Massachusetts Institute Of Technology Potent agelastatin derivatives as modulators for cancer invasion and metastasis
US10640508B2 (en) 2017-10-13 2020-05-05 Massachusetts Institute Of Technology Diazene directed modular synthesis of compounds with quaternary carbon centers
US11629167B2 (en) 2017-11-09 2023-04-18 Arizona Board Of Regents On Behalf Of Arizona State University Betulastatin compounds
WO2020247054A1 (en) 2019-06-05 2020-12-10 Massachusetts Institute Of Technology Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
WO2022182415A1 (en) 2021-02-24 2022-09-01 Massachusetts Institute Of Technology Himastatin derivatives, and processes of preparation thereof, and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708962A (en) * 1984-12-17 1987-11-24 Harbor Branch Oceanographic Institution, Inc. Antiviral and antitumor cyclohexadienone compositions

Also Published As

Publication number Publication date
JPH02295986A (ja) 1990-12-06
DK0397336T3 (da) 1995-06-06
ES2070276T3 (es) 1995-06-01
EP0397336B1 (de) 1995-03-22
EP0397336A2 (de) 1990-11-14
CA2010886A1 (en) 1990-10-26
DE69017946T2 (de) 1995-09-14
ATE120193T1 (de) 1995-04-15
JP2929025B2 (ja) 1999-08-03
US4940726A (en) 1990-07-10
EP0397336A3 (de) 1991-03-27

Similar Documents

Publication Publication Date Title
DE69017946D1 (de) Zellwachstum hemmende makrozyklische Lactone namens Combretastatin D-2.
ATE114463T1 (de) Azaspirane mit immunmodulierender wirkung.
JPS5736260B2 (de)
ES2077138T3 (es) Derivados de aminocumarano, su produccion y su uso.
MY115307A (en) Preparation for epidermis
ATE78465T1 (de) Kathartica.
IT1209415B (it) Composizioni di sterilizzanti di vinilalogenuri, di bassa tossicita'.
ATE289810T1 (de) Ecteinascidinderivate
ES8700262A1 (es) Un compuesto
ES2093037T3 (es) Derivados de beta-lactama y su preparacion.
IE812453L (en) Novel guanidine derivatives.
FR2374302A1 (fr) Nouvelles halogenethyl-sulfones, leur procede de preparation et leur application comme substances de croissance des plantes
FR2358401A1 (fr) Nouveaux derives d'oxadiazine, leur procede de preparation et leur application comme insecticides
IE40395L (en) 2,3- dihydrobenzofuranyl -7-n-methylcarbamates;¹insecticides
DK471979A (da) Estere af 1,1,2-triphenylalkenderivater
ES517995A0 (es) Un procedimiento para la preparacion de un compuesto de hidroxibencilaminobenceno, dotado de propiedades antiinflamatorias.
FR2355500A1 (fr) Composition antimicrobienne a base de 1-acyloxy-2-imidazolyl-1-phenylethanes
ES2058192T3 (es) Diesteres de acido fosforico y sus sales.
IE873442L (en) Cephalosporin derivative
ES2096628T3 (es) Derivados heterociclicos.
DK0713485T3 (da) Thiocarbamoylforbindelser som mikrobicider
FR2359836A1 (fr) Ethers de zearaline utiles comme agents promoteurs de la croissance
FR2452497A1 (fr) Fortimicine an et son application comme intermediaire dans la synthese d'antibiotiques
ATE79259T1 (de) Prophylaktische und heilende zusammensetzung enthaltende eine 8-chlorbenzothiazepin-verbindung und dessen verwendung.
FI904033A0 (fi) Nya 1,3-oxaziner.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition